• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 472

Xylanase enzyme preparation derived from Bacillus licheniformis carrying a gene encoding a modified xylanase from B. licheniformis

Intended Use: For use in the baking industry at a level of 0.5 grams of xylanase enzyme preparation per 100 kilograms of flour to modify arabinoxylans, resulting in improved dough handling and bread characteristics
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
Notifier Address: 77 Perry Chapel Church Road, P.O. Box 576
Franklinton, NC 27525
Date of filing: May 23, 2013
GRAS Notice (releasable information): GRN 472 (in PDF) (3.1 MB)
Date of closure: Jan 10, 2014
FDA's Letter: FDA has no questions